Gillian is a postdoctoral Research Fellow in Palliative Care. She specialises in mixed method research and is particularly interested in their application to conduct Process Evaluations of trials that use complex interventions in real world settings. Gillian is currently a Research Fellow as part of the Process Evaluation team on the CANFit study. The CANFit study is exploring the use of a personalised home-based exercise programme with support from exercise professionals, compared with NHS standard care on survival outcomes, for those with a higher risk of early recurrence of lung, breast, and bowel cancers. This study is funded by Yorkshire Cancer Research.
Gillian is a postdoctoral Research Fellow in the Wolfson Palliative Care Research Centre. Her main research focus is to tackle complex healthcare challenges primarily in palliative care and oncology. She has worked on various studies conducting mixed methods research including quantitative data collection/analysis, study site engagement and retention, co-design, and process evaluation through the application of implementation theory in surveys and interviews. A notable recent study was the DAMPen-Delirium study- Improving the Detection, Assessment, Management, and Prevention of Delirium in Hospices. Gillian was the Research Fellow on this 2-year study which was part of the TRANSFORM Project funded by Yorkshire Cancer Research.
More information on the DAMPen-Delirium study
Key recent publications
Pearson M, Jackson G, Jackson C, Boland J, Featherstone I, Huang C, et al. Improving the Detection, Assessment, Management and Prevention of Delirium in Hospices (the DAMPen-D study): protocol for a co-design and feasibility study of a flexible and scalable implementation strategy to deliver guideline-adherent delirium care. BMJ Open. 2022;12(7):e060450.
Jackson G, Jackson C, Boland JW, Featherstone I, Huang C, Ogden M, et al. Improving the Detection, Assessment, Management, and Prevention of Delirium in Hospices (the DAMPen-
D study): Feasibility Study of a flexible and scalable implementation strategy to deliver guideline-adherent delirium care Palliative Medicine. 2024;[accepted for publication].
Key recent presentations:
INTERNATIONAL CONFERENCE ORAL PRESENTATIONS:
Jackson, G., Pearson, M., Jackson, C., Boland, J., Featherstone, I., Huang, C., Ogden, M., Sartain, K., Siddiqi, N., Twiddy, M. & Johnson, M.J (2022) The DAMPen-D study: Improving the detection, assessment, management, and prevention of delirium in hospices. Presented at the i3 Creating Connections Palliative Care Conference, 28th June 2022
Jackson, G., Pearson, M., Jackson, C., Boland, J., Featherstone, I., Huang, C., Ogden, M., Sartain, K., Siddiqi, N., Twiddy, M. & Johnson, M.J. Using an implementation strategy to improve guideline-adherent delirium care in hospices: the Detection, Assessment, Management and Prevention of Delirium in Hospices (DAMPen-D) process evaluation. Presented at the Australasian Delirium Association (ADA) Conference, Sydney, Australia, 3rd November 2023.
Jackson, G., Pearson, M., Jackson, C., Boland, J., Featherstone, I., Huang, C., Ogden, M., Sartain, K., Siddiqi, N., Twiddy, M. & Johnson, M.J. How can we use theory to develop and implement interventions to improve delirium care? Recent research from palliative care. Symposium presentation at the Australasian Delirium Association (ADA) Conference, Sydney, Australia, 3rd November 2023.
NATIONAL CONFERENCE ORAL PRESENTATIONS:
Jackson, G., Pearson, M., Jackson, C., Boland, J., Featherstone, I., Huang, C., Ogden, M., Sartain, K., Siddiqi, N., Twiddy, M. & Johnson, M.J (2022) The DAMPen-D study: Improving the detection, assessment, management, and prevention of delirium in hospices. Presented at Hospice UK conference, Glasgow, 22-24 November 2022.
NATIONAL CONFERENCE POSTER PRESENTATIONS:
Jackson, G., Pearson, M., Jackson, C., Boland, J., Featherstone, I., Huang, C., Ogden, M., Sartain, K., Siddiqi, N., Twiddy, M. & Johnson, M.J (2023) Using an implementation strategy to improve guideline-adherent delirium care in hospices: Emerging findings of the DAMPen-Delirium feasibility study. Presented at Palliative Care Congress, Edinburgh, 16-17 March 2023